Showing results (141-150 of 213) with videos related to
Sort By:
Pageof 22
Molecular Cancer Therapeutics|August 20, 2013
Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cellsRan-Yi Liu, Zizheng Dong, Jianguo Liu, et al.Plos One|December 21, 2013
Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferationWangbing Chen, Wei Guo, Mei Li, et al.Journal of Translational Medicine|October 16, 2013
Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cellsLi-xia Li, Yan-ling Zhang, Ling Zhou, et al.Biochemical and Biophysical Research Communications|November 26, 2013
An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cellsRan-Yi Liu, Ling Zhou, Yan-Ling Zhang, et al.Biochemical Pharmacology|March 13, 2023
Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3Xue-Xia Yuan, You-Fa Duan, Chunxiang Luo, et al.Oncotarget|September 5, 2015
RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signalingYun Tian, Lijun Qin, Huijuan Qiu, et al.Journal for Immunotherapy of Cancer|February 13, 2021
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancerQi-Hua Peng, Chun-Hua Wang, Hong-Min Chen, et al.Cancer Letters|January 23, 2016
MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathwaysRanran Tang, Xiangdong Xu, Wenjing Yang, et al.Oncotarget|July 10, 2015
High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapyXiang Fu, Jiali Hu, Hong-yu Han, et al.Cancer Science|April 2, 2020
Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcomaChuangzhong Deng, Yanyang Xu, Jianchang Fu, et al.Pageof 22